Buyer · Utility / sector
CHU Lyon
Lyon cedex 08 · Rhône
Track this recordFree account — get alerted when a contract here runs out.
Awards
7
Total awarded
€9.5m
7 / 7 with a value
Suppliers
6
Last updated
14 Jan 2026
Current incumbents
| Sector | Supplier | Contract value | Contract end |
|---|---|---|---|
| Medical equipment and pharmaceuticals | CELLTRION HEALTHCARE FRANCE SAS | €220,320 | 31 May 2027 |
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| OMALIZUMAB | CHU Lyon | CELLTRION HEALTHCARE FRANCE SAS | €220,320 | 14 Jan 2026 |
| BETA 2 STIMULANTS INHALES TRES LONGUE DUREE D'ACTION | CHU Lyon | NOVARTIS PHARMA SAS | €54,796 | 14 Jan 2026 |
| BETA 2 STIMULANTS + ANTICHOLINERGIQUE TRES LONGUE DUREE D'ACTION | CHU Lyon | GLAXOSMITHKLINE | €31,538 | 14 Jan 2026 |
| DERMOCORTICOIDE D'ACTIVITE MODEREE (GROUPE II) | CHU Lyon | ALLIANCE PHARMA FRANCE | €35,024 | 14 Jan 2026 |
| Némolizumab NEMLUVIO | CHU Lyon | GALDERMA INTERNATIONAL | €9,117,600 | 5 Nov 2025 |
| DOIGTIER 2 DOIGTS NON STERILE POLYETHYLENE | CHU Lyon | DIDACTIC | €28,553 | 3 Nov 2025 |
| DOIGTIER 2 DOIGTS NON STERILE POLYETHYLENE | CHU Lyon | DIDACTIC | €57,105 | 3 Nov 2025 |